The hospital segment held the largest market share of 48.7% in 2024, supported by high patient volume, availability of advanced therapies, and inpatient prescriptions. On the basis of route of administration, the prescription drugs market is segmented into oral, topical, parenteral, and others. The oral segment accounted for the largest revenue share of 51.2% in 2024, due to ease of use and widespread application in chronic disease management.
INSTITUTE REPORT
Improved healthcare infrastructure and increasing awareness about eye health are boosting demand for effective treatments. Additionally, advancements in pharmaceutical technology and expanding access to healthcare in emerging countries are fueling market growth, making Asia-Pacific a key region for ophthalmic drug development and sales. The Japan prescription drugs market is gaining momentum, supported by a rapidly aging population, a high incidence of chronic illnesses, and widespread access to universal healthcare.
Which Region Held The Dominating Position In The Global Prescription Drugs Market?
By formulation, the sprays segment is expected to grow at the fastest rate during the forecast period. Sprays use atomization to transform a liquid or solid composition into a dynamic combination spread across a gas. Demand for innovative items rises as people become more conscious of the treatment and management of illnesses. Furthermore, it is projected that the region’s need for and accessibility to treatment choices would increase as a result of growing domestic firms’ investments there and mergers with important players.
The Global Generic Drug Market: Trends, Opportunities, And Challenges
The resultant shift toward complex biologics is recalibrating revenue structures within the generic drugs market. Adults (ages 15-64) accounted for the largest share of 64.83% of the pharmaceutical market in 2024. The rising use of prescription drugs in this demographic, particularly for conditions like hypertension and diabetes, is expected to continue driving market growth. The pediatric and adolescent segment is also anticipated to grow significantly due to the increasing number of pediatric drug approvals and the rise in childhood conditions requiring medical treatment.
- The rising occurrence of cancerhas been attributed to lifestyle changes in an increasingly geriatricpopulation in both developed countries and emerging economies.
- Brazil is the key market, driven by government health initiatives and investments in local biopharmaceutical manufacturing.
- A number of companies producing generic equivalents of many drugs, such as Dr Reddy’s Laboratories Ltd., and Lupin Pharmaceuticals, Inc., are also expected to launch a number of products in the forecast period.
- Neoplastic disorders, like lung cancer, involve abnormal cell growth in the respiratory system, which can lead to serious health complications.
- The companies that successfully navigate these challenges will not only survive but will define the next chapter of the global generic drug market, solidifying their role as indispensable pillars of worldwide healthcare.
Cell-Based Vaccine Market 2025 Size, Growth And Forecast
Moreover, the rising approval of these drugs increases the presence of these drugs across the country, further driving the market growth. Rising R&D initiatives by key players for the development of specialty drugs across serious indications further augment the growth of the market. Artificial intelligence (AI) can play a vital role in developing novel generic drugs by suggesting excipients required for preparing a formulation. AI and machine leaing (ML) algorithms can predict the pharmacokinetic and pharmacodynamic properties of generic drugs. AI and ML can also automate the manufacturing process of generic drugs, reducing manual errors. Moreover, AI and ML can be incorporated into retail and hospital pharmacies to deliver correct medications to patients, decreasing medication dispensing errors.
For instance, aspirin is frequently used in people with a history of heart disease or who are at high risk of developing heart disease to prevent heart attacks, strokes, and other cardiovascular disorders. In the same way, acetaminophen and ibuprofen are frequently used to lessen pain and inflammation brought on by ailments including headaches, chronic pain in the back, and arthritis. Thus, the increasing prevalence of various diseases drives the U.S. over the counter (OTC) drugs market. The future of the generic drug market will be defined by the interplay of these strategic and policy choices. The companies and countries that successfully adapt to this new era of complexity and innovation will not only lead the industry but will also play a pivotal role in ensuring the future of accessible and sustainable healthcare for a global population.
In addition, small molecules often exhibit better membrane penetration, allowing for targeting intracellular pathways, further solidifying their position in drug development pipelines. According to the World Health Organization, between 2 and 3 million cases of non-melanoma skin cancer and 132,000 cases of melanoma skin cancer are detected each year. Furthermore, the global prevalence of psoriasis ranges from 0.09 percent to 11.43%, making it a severe global disease affecting at least 100 million people. The market for sophisticated topical products is likely to rise in the coming years, as topical drug administration is the first line of treatment for the majority of skin illnesses.
Get Free Sample Of This Report
On average, it takes about 14 years for a medication to make this transition, reflecting the depth of research, regulatory examinations, and post-marketing evaluations for safety and efficacy. Additionally, marketing budgets for OTC products can be significant, with an average of $30-50 million allocated per major product launch. The financial and resource investments involved in R&D highlight the market’s competitiveness, which is evident through the output of more than 50,000 retail locations stocking the average OTC drug product. In parallel, the distribution chain covers everything from major pharmacy networks to smaller markets, making it easier for upwards of 250 million Americans to consistently access OTC options. Each new product or reformulation requires balancing cost, innovation, and consumer expectations.
About EU Drug Markets
In general, leaders stressed the need for creative leadership to adopt new pharmaceutical advances and develop mechanisms that would guarantee the accessibility and affordability of upcoming therapies. This group is the largest and consumes various pharmaceutical products for better health and to improve quality of life. With over 3,500 medications now in development, precision medicine will continue to be a major area of focus for pharmaceutical innovation. The field’s future is hinted at by Germany’s ambitious ambition to use whole-genome sequencing in regular healthcare, the emergence of mRNA vaccines, and next-generation treatments that use CRISPR technology. Artificial intelligence (AI) is emerging as an important tool in the healthcare sector, as it helps understand the action mechanism of drugs.
What Are The Hurdles In The Respiratory Drugs Market?
The Asia-Pacific region is the fastest-growing pharmaceutical market in the world, driven by rising incomes, expanding healthcare access, and large populations. Within this region, India, China, and Japan represent three vastly different but equally critical markets for the global generic drug industry. Across the globe, healthcare systems are grappling with the challenge of rising costs, driven by aging populations, technological advancements, and the high price of innovative medicines. Table 2 showsdrug expenditures and the total number of prescriptions from 2017 to2022 for small molecule drugs and biological products. Totalinflation-adjusted expenditures on prescription drugs grew from $522billion in 2017 to $618 billion in 2022, an 18.4 percent increase.
Key Patent Expiries
The rising demand for oncology drugs such as keytruda, revlimid and opdivo for the treatment of chronic diseases such as melanoma, multiple myeloma, and lung cancer, among others, is further driving the segmental growth in the market. In January 2025, Sunshine Biopharma Inc. announced the release of two new generic prescription drugs by its Canadian subsidiary, Nora Pharma Inc. Dr. Steve Slilaty, CEO of Sunshine Biopharma, commented that the launch of two generic drugs could fulfill the company’s commitment to expand its presence in the Canadian generic drug market. Exploring partnerships and collaborations with other industry players can provide manufacturers with new avenues for growth and expansion.
See Markets More Clearly Opportunities More Often
Alternatively, the user can search these key findings using the different filter options by region, topic, market, and more, or search by keyword using the search bar, by going to the “Advanced Search” section. Each key finding contains insights presented through succinct messages, supported by a number of data visualizations based on the latest available data, including interactive graphs, infographics and maps. The data and visualizations from each key finding can be downloaded by clicking on the corresponding link. The Online World Drug Report 2024 contains more than 100 key findings with over 300 data visualizations. This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033.
Technological innovations in drug delivery systems and expanding access to healthcare in emerging economies also contribute to market expansion. Strategic collaborations and investments in R&D continue to drive product development and market competitiveness. The global pharmaceutical market size was estimated at USD 1,645.75 billion in 2024 and is projected to reach USD 2,350.43 billion by 2030, growing at a CAGR of 6.12% from 2025 to 2030. The market is driven by rising chronic disease prevalence, aging populations, and increased healthcare spending.
Asia Pacific is expected to be the fastest-growing region in the projected timeframe, as a rising number of aging populations with chronic conditions like hypertension, diabetes, and dementia are significantly driving the growth of the drugs market. Although novel advanced technologies in drug delivery, including nanotechnology, microencapsulation, and 3D printing, are optimizing drug efficacy and bioavailability, which leads to the enhanced demand for drugs. By product type, the over-the-counter (OTC) drugs segment is expected to be the fastest CAGR growing in the upcoming years. Nowadays, consumers are widely adopting OTC drugs to resolve insignificant ailments and track their complete well-being, because of their convenience and reasonable compared to prescription drugs. Also, rising emphasis on proactive health management is resulting in a greater demand for OTC products, which is coupled with self-care and preventive measures.
